Organization · Venture Capital
Thuja Capital
Thuja Capital is an early-stage venture capital firm based in Utrecht, Netherlands, specializing in investments in innovative life science companies focused on healthcare. The firm actively supports its portfolio companies through its extensive network.
Overview
What Thuja Capital does
What Thuja Capital is
Thuja Capital is an early-stage venture capital firm based in Utrecht, Netherlands, specializing in investments in innovative life science companies focused on healthcare. The firm actively supports its portfolio companies through its extensive network.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2006
- Approximate age
- About 20 years
- Structured capabilities
- Funder
- Last reviewed
- March 27, 2026
Official channels
Find Thuja Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Thuja Capital as a funder
Investment thesis
Thuja Capital focuses on early-stage investments in innovative life science companies, aiming to translate scientific advancements into clinical applications.
Focus narrative
Thuja Capital invests in both biotech and medtech companies, providing early-stage funding and strategic support to help these companies overcome initial challenges and achieve key milestones. The firm is dedicated to fostering innovation in the life sciences sector.
Value beyond capital
Thuja Capital provides hands-on support to its portfolio companies, leveraging extensive networks and advisory boards to facilitate the transition from scientific research to market-ready medical products. The firm is known for its strong scientific due diligence and active involvement in the development process.
Focus and fit
- Stages
- Seed · Series A
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 10
- Recorded notable exits
- ArgenX, NightBalance, MILabs, and Okapi Biosciences
Portfolio context
Notable portfolio companies include: Alesta Therapeutics: Focused on innovative biotech solutions. ArgenX: A leading biotech company with a market cap of over $16.5B. NightBalance: Developed a device for sleep apnea. MILabs: Specializes in molecular imaging technologies. EsoBiotec: Engaged in advanced biotechnological research. PanCancerT: Focused on cancer therapeutics.
Common questions
What to know about Thuja Capital
Upseed classifies Thuja Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.